Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hoshi Iryo-Sanki CoTSE:7634 75 EV-to-EBIT is 3.39 as of Aug. 26, 2026, which is 2% below its 10-year median of 3.46. GuruFocus rates TSE:7634 with a GF Score™ of 75/100 and a GF Value™ of 円4,738.75 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 97 Medical Distribution companies, Hoshi Iryo-Sanki Co ranks better than 95.88% on this metric.
Hoshi Iryo-Sanki Co (TSE:7634) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Hoshi Iryo-Sanki Co's Enterprise Value for the quarter that ended in Mar. 2026 was 円6,892 Mil.
Hoshi Iryo-Sanki Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,047 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoshi Iryo-Sanki Co EV-to-EBIT Related Terms
Hoshi Iryo-Sanki Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Hoshi Iryo-Sanki Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Hoshi Iryo-Sanki Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoshi Iryo-Sanki Co EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hoshi Iryo-Sanki Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Hoshi Iryo-Sanki Co's EV-to-EBIT falls into.
Hoshi Iryo-Sanki Co's current Enterprise Value is 円6,941 Mil.
Hoshi Iryo-Sanki Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,047 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoshi Iryo-Sanki Co (TSE:7634) has a EV-to-EBIT of 3.39 as of Aug. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Hoshi Iryo-Sanki Co and its competitors. This is near median its historical median of 3.46. Over the past decade, Hoshi Iryo-Sanki Co's EV-to-EBIT has ranged from 1.31 to 11.90. According to the industry distribution chart, Hoshi Iryo-Sanki Co ranks #4 out of 97 companies in the Medical Distribution industry, placing it in the top 4.1%.
Is Hoshi Iryo-Sanki Co's EV-to-EBIT too high?
Hoshi Iryo-Sanki Co's current EV-to-EBIT of 3.39 is near median its 10-year median of 3.46. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 11.90. The Medical Distribution industry median EV-to-EBIT is 11.39. Hoshi Iryo-Sanki Co's value of 3.39 is 70.2% below this industry median. Based on the distribution chart, Hoshi Iryo-Sanki Co ranks #4 out of 97 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Hoshi Iryo-Sanki Co ranks #4 out of 97 companies for EV-to-EBIT. This places Hoshi Iryo-Sanki Co in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 11.39. Hoshi Iryo-Sanki Co's value of 3.39 is 70.2% below this benchmark. Historically, Hoshi Iryo-Sanki Co's own EV-to-EBIT has ranged from 1.31 to 11.90 over the past decade. While the company's 10-year median is 3.46 vs. the industry median of 11.39, Hoshi Iryo-Sanki Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.39, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoshi Iryo-Sanki Co's current EV-to-EBIT of 3.39 is 70.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Hoshi Iryo-Sanki Co and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoshi Iryo-Sanki Co's current EV-to-EBIT is 3.39, which is near median its own 10-year median of 3.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,738.75, compared to a current price of 円5,300.00 — trading 11.8% above its estimated fair value. The current EV-to-EBIT is 3.39, which is near median its 10-year median of 3.46 and 70.2% below the Medical Distribution industry median of 11.39. Hoshi Iryo-Sanki Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current EV-to-EBIT is 3.39 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued.
The current stock price of 円5,300.00 is trading 11.8% above its estimated GF Value™ of 円4,738.75.
GuruFocus considers Hoshi Iryo-Sanki Co to be Modestly Overvalued.
Key valuation signals for TSE:7634:
EV-to-EBIT: 3.39 (near median its 10-year median of 3.46)
GF Value™: 円4,738.75 vs. price of 円5,300.00 (11.8% above fair value)
Industry Position: 70.2% below the Medical Distribution median (#4 of 97)
No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
75GF Score
Get the complete analysis for TSE:7634
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7634 has been successfully added to your 
